WINSTON ROY
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to WINSTON ROY. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| PCRX | Chief Medical Officer | Sale | 509 | $34.88 | $17,754 | Aug 2, 2023 |
| PCRX | Chief Medical Officer | Award / Grant | 10,950 | — | — | Jun 14, 2023 |
| PCRX | Chief Medical Officer | Sale | 1,779 | $38.99 | $69,363 | Jun 7, 2023 |
| PCRX | Chief Medical Officer | Sale | 476 | $55.70 | $26,513 | Aug 3, 2022 |
| PCRX | Chief Medical Officer | Sale | 115 | $63.40 | $7,291 | Jun 6, 2022 |
| PCRX | Chief Medical Officer | Option Exercise | 10,000 | $48.15 | $481,500 | Nov 4, 2021 |
| PCRX | Chief Medical Officer | Award / Grant | 5,000 | — | — | Aug 3, 2021 |
| PCRX | Chief Clinical Officer | Award / Grant | 7,000 | — | — | Jun 9, 2021 |
| PCRX | Chief Clinical Officer | Sale | 2,276 | $61.04 | $138,927 | Jun 4, 2021 |
| PCRX | Chief Clinical Officer | Sale | 16,363 | $70.36 | $1,151,301 | Mar 31, 2021 |
| PCRX | Chief Clinical Officer | Sale | 5,000 | $62.00 | $310,000 | Nov 13, 2020 |
| PCRX | Chief Clinical Officer | Award / Grant | 14,000 | — | — | Jun 9, 2020 |
| PCRX | Chief Clinical Officer | Purchase | 2,500 | $36.50 | $91,250 | Mar 11, 2020 |
| PCRX | Chief Clinical Officer | Award / Grant | 5,600 | — | — | Jun 4, 2019 |